aTyr Pharma | LIFE - Bénéfice Avant Impôts





Bénéfice Avant Impôts Changement Date
Alterity Therapeutics Limited AUD -4.74M 3.53M 2024-12
Ardelyx USD -400K 467K 2025-12
aTyr Pharma USD -25.75M 6.22M 2025-09
Biogen USD 557.3M 186.7M 2025-09
Bristol-Myers Squibb USD 3.11B 1.34B 2025-09
Cipla INR 11.69B 6.85B 2025-12
Clal Biotechnology ILS 86.82M 17.9M 2022-12
Compugen USD 56.84M 63.78M 2025-12
CSL USD 2.61B 1.21B 2025-12
Curis USD 19.36M 33.34M 2025-12
Galapagos EUR -221.49M 117.07M 2025-09
GlaxoSmithKline GBP 1.23B 1.23B 2025-12
Grifols EUR 257.85M 190.87M 2024-12
Novartis USD 4.64B 445M 2025-12
Roche Holding CHF 4.79B 3.01B 2025-06
United Therapeutics USD 444M 6M 2025-12
Xoma USD 15.98M 24.58M 2024-06